SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-204281
Filing Date
2022-07-28
Accepted
2022-07-28 09:20:09
Documents
14
Period of Report
2022-07-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d323810d8k.htm   iXBRL 8-K 32990
2 EX-10.1 d323810dex101.htm EX-10.1 177591
  Complete submission text file 0001193125-22-204281.txt   415606

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA btmd-20220727.xsd EX-101.SCH 3570
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE btmd-20220727_def.xml EX-101.DEF 13881
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE btmd-20220727_lab.xml EX-101.LAB 22723
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btmd-20220727_pre.xml EX-101.PRE 14709
8 EXTRACTED XBRL INSTANCE DOCUMENT d323810d8k_htm.xml XML 5701
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

IRS No.: 851791125 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40128 | Film No.: 221113054
SIC: 2833 Medicinal Chemicals & Botanical Products